Ubiquinol 100 mg (60 Softgels)

What it is: Ubiquinol 100 mg is a gluten-free, soy-free CoQ10 formula developed by DaVinci Labs, featuring Kaneka Ubiquinol™ — the patented, stabilized active reduced form of Coenzyme Q10 produced by Kaneka Corporation (Q+®, Kaneka Ubiquinol™, registered or pending trademarks of Kaneka Corp.) — delivered at 100 mg per softgel in a medium chain triglyceride and sunflower lecithin base for enhanced fat-soluble absorption. Ubiquinol is the electron-rich, reduced form of CoQ10 that the body must produce endogenously from ubiquinone (the oxidized form found in most CoQ10 supplements) through an NADPH-dependent reduction step — a conversion that declines significantly with age, oxidative stress, and statin medication use, making direct ubiquinol supplementation increasingly clinically relevant for clients over 35. Human pharmacokinetic studies have demonstrated that Kaneka Ubiquinol™ achieves 3.75 times higher plasma CoQ10 concentration at eight hours post-dosing compared to equivalent doses of conventional ubiquinone, establishing it as the most bioavailable and clinically efficient CoQ10 form available. Designed for practitioner-directed use in cardiovascular, mitochondrial, healthy aging, periodontal, liver, and exercise tolerance protocols. How it works: Ubiquinol 100 mg supports cellular energy production, cardiovascular function, and antioxidant defense through CoQ10's essential dual roles as a mitochondrial electron carrier and lipid-soluble antioxidant. As the electron-rich reduced form of CoQ10, Ubiquinol directly functions as the mobile electron carrier between mitochondrial respiratory chain Complexes I/II and Complex III — shuttling electrons along the inner mitochondrial membrane to maintain the electrochemical proton gradient that drives ATP synthase and powers ATP production in every cell. This electron transport function is particularly critical in "high energy" organs — the heart, brain, skeletal muscles, liver, kidneys, and pancreas — where hundreds of mitochondria per cell sustain the highest metabolic demands, making CoQ10 availability a direct determinant of cellular energy capacity and organ function. As a lipid-soluble antioxidant located precisely within the inner mitochondrial membrane where reactive oxygen species (ROS) are generated during oxidative phosphorylation, Ubiquinol neutralizes superoxide and lipid peroxyl radicals at their site of production — protecting mitochondrial membrane phospholipids, mitochondrial DNA, and respiratory chain proteins from oxidative damage. Ubiquinol additionally regenerates Vitamin E from its oxidized tocopheroxyl radical form, amplifying the cell's overall lipid-soluble antioxidant network. Cardiovascular support is provided through Ubiquinol's role in cardiac muscle ATP production — the heart's continuous demand for ATP making it particularly sensitive to CoQ10 insufficiency — alongside its antioxidant protection of LDL particles from oxidative modification. Periodontal health support reflects CoQ10's role in supporting the high energy demands of gingival tissue repair and immune cell function. Endogenous CoQ10 production declines after age 35 and is further depleted by HMG-CoA reductase inhibitors (statins), which block the mevalonate pathway shared by both cholesterol and CoQ10 biosynthesis — making Ubiquinol supplementation particularly clinically relevant for statin users. When to use it: Ubiquinol 100 mg is appropriate for practitioner-directed use in adult clients aged 35 and over requiring CoQ10 supplementation for mitochondrial energy production, cardiovascular support, antioxidant protection, exercise tolerance, and healthy aging — particularly those with documented CoQ10 insufficiency, statin-associated myopathy or fatigue, elevated cardiovascular risk, high oxidative stress burden, periodontal health concerns, or liver support needs. One softgel daily with a meal supports optimal fat-soluble CoQ10 absorption in the presence of dietary fat. For clients with significant CoQ10 depletion or elevated clinical needs, practitioners may individualize dosing upward as clinically indicated.